Evidence in Knee Surgery 2020 Banner Desktop
Evidence in Knee Surgery 2020 Banner mobil

Congress Cancellation

Today the Congress Chairmen together with the organiser Intercongress have made the difficult decision to cancel the congress Evidence in Knee Surgery & Combined TIRM Symposium, originally scheduled from 3 – 5 December 2020.

They came to this conclusion considering the global implications of the COVID-19 pandemic, especially the travel restrictions for international speakers and delegates.


3 – 5 December 2020


marinaforum Regensburg

Congress Chairmen

Peter Angele,
Philipp Niemeyer,
Tim Spalding,
Peter Verdonk

Dear Colleagues, Ladies and Gentlemen,

The question of clinical and scientific evidence is a topic that is increasingly gaining importance in operative medicine from various aspects. As surgeons and scientists, we question our daily actions and strategies and compare them with other methods in order to participate in the further development and improvement of therapeutic concepts. On the other hand, our treatments are increasingly being questioned by patients and payers, who also demand proof of scientific evidence as the basis for their decision and also for the acceptance of therapies in the reimbursement systems.

We would like to take account of this aspect and this development in Regensburg, 3-5 December 2020 with a combined meeting of an already established conference called TIRM (Translation in Regenerative Medicine) and a new and innovative congress entitled “Evidence in Knee Surgery”. The event will focus on the regenerative “cartilage repair”. This also represents a very well-suited subject area – also due to the regulatory requirements and the problems of reimbursement – in order to discuss the topic of evidence and to draw common insights and conclusions.

We wish to emphasise the encompassing relevance of the topic through an international congress design. Specifically, we want to discuss the differences between countries and their relevance to the clinical practice. Here not only clinically active colleagues but also scientists, industry employees and politicians with involvement in the reimbursement of therapies will be invited as speakers, since all aspects and perspectives should be recognised.

The TIRM conference has a special format. One topic, this year “cell-based treatment for cartilage repair”, is discussed from a preclinical and a clinical perspective. It is a great platform for scientists, clinicians and industry to learn more from each other.

In addition to the classic lectures, the congress will be supplemented by an interactive workshop and a discussion forum on 4 topic blocks aimed at working towards a consensus and summarising statements of the participants and experts. In this way a practical utility value is to be achieved through direct discussion, which extends beyond the duration of the congress by publication of the consensus states.

We would be very happy if you would join us in Regensburg, 3 – 5 December 2020, to discuss with us.

Peter Angele, Philipp Niemeyer, Tim Spalding and Peter Verdonk

IC Logo
Winglet Logo negativ
Uniklinik Freiburg Logo